ClinVar Miner

Submissions for variant NM_004086.3(COCH):c.1055C>G (p.Thr352Ser)

gnomAD frequency: 0.51720  dbSNP: rs1045644
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000221727 SCV000268888 benign not specified 2012-05-07 criteria provided, single submitter clinical testing Thr352Ser in Exon 11 of COCH: This variant is not expected to have clinical sign ificance because it has been identified in 37.1% (2602/7020) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs1045644).
PreventionGenetics, part of Exact Sciences RCV000221727 SCV000306796 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000616871 SCV000386506 benign Autosomal dominant nonsyndromic hearing loss 9 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000221727 SCV000730998 benign not specified 2017-05-09 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000616871 SCV000745498 benign Autosomal dominant nonsyndromic hearing loss 9 2015-09-21 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001582722 SCV001821550 benign Hearing loss, autosomal recessive 110 2021-07-22 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000616871 SCV001821551 benign Autosomal dominant nonsyndromic hearing loss 9 2021-07-22 criteria provided, single submitter clinical testing
Invitae RCV002054369 SCV002379780 benign not provided 2024-01-31 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000616871 SCV000733377 benign Autosomal dominant nonsyndromic hearing loss 9 no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000221727 SCV001951041 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.